Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Cash from Financing Activities (2019 - 2025)

Entera Bio has reported Cash from Financing Activities over the past 7 years, most recently at $174000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 94.59% year-over-year to $174000.0, compared with a TTM value of $13.7 million through Dec 2025, up 206.3%, and an annual FY2025 reading of $13.7 million, up 206.3% over the prior year.
  • Cash from Financing Activities came in at $174000.0 for Q4 2025, down from $250000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $13.3 million in Q1 2025 to a low of -$51000.0 in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was $250000.0 (2025), compared with a mean of $3.3 million.
  • The largest YoY upside for Cash from Financing Activities was 44356.67% in 2025 against a maximum downside of 104.19% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $21000.0 in 2021, then tumbled by 38.1% to $13000.0 in 2022, then skyrocketed by 46292.31% to $6.0 million in 2023, then plummeted by 46.66% to $3.2 million in 2024, then crashed by 94.59% to $174000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Cash from Financing Activities are $174000.0 (Q4 2025), $250000.0 (Q3 2025), and -$51000.0 (Q2 2025).